New York Life Investment Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $548K | Buy |
+12,701
| New | +$548K | 0.01% | 752 |
|
|
2024
Q3 | – | Sell |
-13,116
| Closed | -$332K | – | 848 |
|
|
2024
Q2 | $332K | Buy |
13,116
+1,406
| +12% | +$35.6K | ﹤0.01% | 818 |
|
|
2024
Q1 | $362K | Sell |
11,710
-9,280
| -44% | -$287K | ﹤0.01% | 1167 |
|
|
2023
Q4 | $847K | Sell |
20,990
-450
| -2% | -$18.2K | 0.01% | 698 |
|
|
2023
Q3 | $565K | Sell |
21,440
-3,417
| -14% | -$90.1K | 0.01% | 749 |
|
|
2023
Q2 | $428K | Sell |
24,857
-2,046
| -8% | -$35.2K | ﹤0.01% | 891 |
|
|
2023
Q1 | $446K | Buy |
+26,903
| New | +$446K | 0.01% | 1140 |
|